APICHEM Laboratories is an API manufacturer based in India. It holds 13 active US drug master files across a filed portfolio of 10 molecules. Customs aggregates show $622K of exports covering 47 molecules to 8 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Yadadri Bhuvanagiri District, India | 3018722849 |
| Molecule | Regulators | Docs |
|---|---|---|
| Avatrombopag | US FDA | 2 |
| Lercanidipine | US FDA | 2 |
| Resmetirom | US FDA | 2 |
| Azathioprine | US FDA | 1 |
| Bempedoic Acid | US FDA | 1 |
| Cenobamate | US FDA | 1 |
| Ethionamide | US FDA | 1 |
| Mavacamten | US FDA | 1 |
| Urapidil | US FDA | 1 |
| Xanomeline | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.3M | 7 |
| 2025 | Not reported | $622K | 8 |
| 2024 | Not reported | $56K | 6 |
| 2023 | Not reported | $6K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. APICHEM Laboratories comes back tiered against every other supplier able to file there.
Start for free